Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Can minors truly consent to reversible puberty blockers in gender-affirming health care?

Logan Vayder
Conditions
July 17, 2023
Share
Tweet
Share

Gender-affirming health care (GAH) is a rapidly developing sector within the medical profession that can include indirect therapies such as counseling, direct therapies such as hormone treatments, puberty blockers, or gender-affirming surgeries. A main ethical concern with GAH resides in its use on adolescents, and this paper will primarily explore the use of puberty blockers, sometimes called GnRH analogues, on minors.

Considering that most children start puberty around the age of 10 or 11, the age at which puberty blockers can be used for the greatest effect is almost always before the age of assent in minors (around age 15). Legal access differs widely between states, with some states not allowing the prescription of puberty blockers to anyone under 18, but guidelines from the World Professional Association for Transgender Health (WPATH) suggest the use of puberty blockers much earlier, as early as age nine in individuals who have attained Tanner Stage II. This raises the ethical question of whether minors can assent to and receive non-invasive puberty blockers.

This essay will consider the safety of puberty blockers in an examination of the common claim that they are fully reversible. This paper may not apply to all youth who are considering undergoing GAH, and special consideration for each individual will continue to be paramount for doctors who prescribe GAH to minors.

The Mayo Clinic guidelines for gender-diverse persons interested in starting puberty blockers state that “GnRH analogues don’t cause permanent physical changes. Instead, they pause puberty.” In the same section, a further claim is made: “When a person stops taking GnRH analogues, puberty starts again.” Similarly, the WPATH Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People lists “the use of GnRH analogues to suppress estrogen or testosterone production and consequently delay the physical changes of puberty” as “fully reversible interventions.” However, a general lack of evidence creates concerns about the certainty of these claims.

A 2017 essay on treating gender dysphoria concluded that “the evidence for the safety and efficacy of puberty suppression is thin, based more on the subjective judgments of clinicians than on rigorous empirical evidence.” While this paper is over six years old, the disturbing lack of evidence for the full reversibility of puberty blockers still permeates discussions today. Instead of new evidence quelling fears, three years ago the National Health Service (NHS) of England changed its statement on puberty blockers from endorsing their full reversibility to now claiming that “little is known about the long-term side effects of hormone or puberty blockers in children with gender dysphoria.” Notably, concerns with the development of brain tissue, bone growth, and psychological effects challenge the reversibility of puberty blockers prescribed to treat gender dysphoria. Despite claims of high certainty in the reversibility of puberty blockers, there is scant evidence that supports the nature of puberty blockers as fully reversible while more and more studies surface claiming the opposite.

The intentionality behind using puberty blockers to treat gender dysphoria greatly differs from the purpose for which puberty blockers were invented, which was to treat precocious puberty in children. Because of this difference, cases arise where puberty blockers are used outside their intended field and may therefore have unknown consequences. This is often the case when puberty blockers are used to treat gender dysphoria.

The fact that children with suppressed precocious puberty between ages 8 and 12 resume puberty at age 13 does not mean that adolescents suffering from gender dysphoria, whose puberty is suppressed beginning at age 12, will simply resume normal pubertal development down the road if they choose to withdraw from the puberty-suppressing treatment…

The use of puberty blockers to treat gender dysphoria remains a highly experimental field with little research to provide adequate justification for their widespread use. Claims of the full reversibility of puberty blockers should be taken with hesitation, considering that they are often the result of biased speculation. Until further research is undertaken to determine the safety of using puberty blockers to treat gender dysmorphia, the risk of wantonly disrupting the natural processes of the human body far outweighs the potential mental health benefits to those struggling with gender dysphoria.

Logan Vayder is a medical ethics student.

Prev

Is obesity really a disease?

July 17, 2023 Kevin 1
…
Next

5 tips for ending office visits on time

July 17, 2023 Kevin 0
…

Tagged as: Pediatrics

Post navigation

< Previous Post
Is obesity really a disease?
Next Post >
5 tips for ending office visits on time

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Related Posts

  • Are negative news cycles and social media injurious to our health?

    Rabia Jalal, MD
  • The rise of gender reveals: a global health perspective

    Steven G. Duncan
  • How social media can help or hurt your health care career

    Health eCareers
  • Sharing mental health issues on social media

    Tarena Lofton
  • 3 ways to advance the credibility of online health information

    Robert Pearl, MD
  • The gender imbalance in nursing

    Cole Edmonson, DNP and Paulette Anest, RN

More in Conditions

  • Does silence as a faculty retention strategy in academic medicine and health sciences work?

    Sylk Sotto, EdD, MPS, MBA
  • Why personal responsibility is not enough in the fight against nicotine addiction

    Travis Douglass, MD
  • AI in mental health: a new frontier for therapy and support

    Tim Rubin, PsyD
  • What prostate cancer taught this physician about being a patient

    Francisco M. Torres, MD
  • Why ADHD in women is finally getting the attention it deserves

    Arti Lal, MD
  • Why ruling out sepsis in emergency departments can be lifesaving

    Claude M. D'Antonio, Jr., MD
  • Most Popular

  • Past Week

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The hidden cost of delaying back surgery

      Gbolahan Okubadejo, MD | Conditions
    • The dreaded question: Do you have boys or girls?

      Pamela Adelstein, MD | Physician
    • Rethinking patient payments: Why billing is the new frontline of patient care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • What happened to real care in health care?

      Christopher H. Foster, PhD, MPA | Policy
    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Residency as rehearsal: the new pediatric hospitalist fellowship requirement scam

      Anonymous | Physician
  • Recent Posts

    • Rediscovering the soul of medicine in the quiet of a Sunday morning

      Syed Ahmad Moosa, MD | Physician
    • An introduction to occupational and environmental medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • Does silence as a faculty retention strategy in academic medicine and health sciences work?

      Sylk Sotto, EdD, MPS, MBA | Conditions
    • Why personal responsibility is not enough in the fight against nicotine addiction

      Travis Douglass, MD | Conditions
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • Alzheimer’s and the family: Opening the conversation with children [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 15 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The hidden cost of delaying back surgery

      Gbolahan Okubadejo, MD | Conditions
    • The dreaded question: Do you have boys or girls?

      Pamela Adelstein, MD | Physician
    • Rethinking patient payments: Why billing is the new frontline of patient care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • What happened to real care in health care?

      Christopher H. Foster, PhD, MPA | Policy
    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Residency as rehearsal: the new pediatric hospitalist fellowship requirement scam

      Anonymous | Physician
  • Recent Posts

    • Rediscovering the soul of medicine in the quiet of a Sunday morning

      Syed Ahmad Moosa, MD | Physician
    • An introduction to occupational and environmental medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • Does silence as a faculty retention strategy in academic medicine and health sciences work?

      Sylk Sotto, EdD, MPS, MBA | Conditions
    • Why personal responsibility is not enough in the fight against nicotine addiction

      Travis Douglass, MD | Conditions
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • Alzheimer’s and the family: Opening the conversation with children [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Can minors truly consent to reversible puberty blockers in gender-affirming health care?
15 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...